Published in J Bacteriol on February 01, 1995
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Bacterial adhesins: common themes and variations in architecture and assembly. J Bacteriol (1999) 3.01
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol (1999) 2.81
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiol Mol Biol Rev (2007) 2.44
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun (2004) 1.68
Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun (2004) 1.57
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol (1999) 1.43
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol (2003) 1.37
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun (2004) 1.30
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun (2009) 1.27
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol (2005) 1.20
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol (1998) 1.13
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun (2003) 1.08
Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia. J Bacteriol (2009) 1.08
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
CooB plays a chaperone-like role for the proteins involved in formation of CS1 pili of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.01
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01
Diazotrophic burkholderia species associated with field-grown maize and sugarcane. Appl Environ Microbiol (2006) 1.00
Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun (2005) 0.98
Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun (1996) 0.97
The level of expression of the minor pilin subunit, CooD, determines the number of CS1 pili assembled on the cell surface of Escherichia coli. J Bacteriol (1999) 0.96
Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol (2003) 0.93
Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction. BMC Syst Biol (2011) 0.91
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax (2004) 0.90
Genetic characterization of a multicomponent signal transduction system controlling the expression of cable pili in Burkholderia cenocepacia. J Bacteriol (2004) 0.89
Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One (2010) 0.89
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med (2000) 0.88
Transcriptional and posttranscriptional control of cable pilus gene expression in Burkholderia cenocepacia. J Bacteriol (2004) 0.86
Assembly of CS1 pili: the role of specific residues of the major pilin, CooA. J Bacteriol (2006) 0.85
Regulation of sulfur assimilation pathways in Burkholderia cenocepacia: identification of transcription factors CysB and SsuR and their role in control of target genes. J Bacteriol (2006) 0.80
Detection of heme-binding proteins in epidemic strains of Burkholderia cepacia. Clin Diagn Lab Immunol (2001) 0.80
The dsbB gene product is required for protease production by Burkholderia cepacia. Infect Immun (1996) 0.78
The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis. Front Microbiol (2016) 0.77
Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother (2003) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60
Rapid and sensitive protein similarity searches. Science (1985) 76.83
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
A rapid boiling method for the preparation of bacterial plasmids. Anal Biochem (1981) 59.01
Determinant of cistron specificity in bacterial ribosomes. Nature (1975) 19.71
Compilation of published signal sequences. Nucleic Acids Res (1984) 11.33
A rapid alkaline extraction method for the isolation of plasmid DNA. Methods Enzymol (1983) 9.81
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85
Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature (1987) 4.72
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Genetics of digalactoside-binding adhesin from a uropathogenic Escherichia coli strain. Infect Immun (1983) 4.03
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
Equilibrium sedimentation of macromolecules and viruses in a density gradient. Fortschr Chem Org Naturst (1962) 3.53
Chaperone-assisted assembly and molecular architecture of adhesive pili. Annu Rev Microbiol (1991) 3.29
Cloning and expression of the pilin gene of Pseudomonas aeruginosa PAK in Escherichia coli. J Bacteriol (1986) 2.77
Nucleotide sequence and transcriptional initiation site of two Pseudomonas aeruginosa pilin genes. J Biol Chem (1986) 2.51
Antigenic quantitation of type 1 fimbriae on the surface of Escherichia coli cells by an enzyme-linked immunosorbent inhibition assay. Infect Immun (1982) 2.19
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Biochemical studies on pili isolated from Pseudomonas aeruginosa strain PAO. Can J Microbiol (1979) 2.08
Cloning and sequencing of the Pseudomonas aeruginosa PAK pilin gene. FEBS Lett (1985) 2.06
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli. Infect Immun (1990) 1.53
Biotinylated DNA probes for exotoxin A and pilin genes in the differentiation of Pseudomonas aeruginosa strains. J Clin Microbiol (1988) 1.44
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Physical map of the Salmonella typhimurium histidine transport operon: correlation with the genetic map. J Bacteriol (1981) 1.16
Molecular cloning and nucleotide sequence of the colonization factor antigen I gene of Escherichia coli. Infect Immun (1989) 1.15
Two unusual pilin sequences from different isolates of Pseudomonas aeruginosa. J Bacteriol (1988) 1.08
Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses. Infect Immun (1994) 1.01
Fimbriation of Pseudomonas cepacia. Infect Immun (1992) 0.96
Plasmids of Pseudomonas cepacia strains of diverse origins. Appl Environ Microbiol (1991) 0.86
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet (2000) 6.96
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science (1997) 4.70
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity (1996) 3.91
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther (2003) 3.85
A Myb-related transcription factor is involved in the phytochrome regulation of an Arabidopsis Lhcb gene. Plant Cell (1997) 3.54
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Non-Alu family interspersed repeats in human DNA and their transcriptional activity. Nucleic Acids Res (1984) 3.30
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Drinking water turbidity and gastrointestinal illness in the elderly of Philadelphia. J Epidemiol Community Health (2000) 3.15
Regulated chromosomal DNA replication in the absence of a nucleus. Mol Cell (1998) 3.11
Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int (2007) 3.06
Antigens displayed on murine B lymphocyte precursors. J Immunol (1981) 2.91
Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol (1995) 2.87
Dendrimer-encapsulated metal nanoparticles: synthesis, characterization, and applications to catalysis. Acc Chem Res (2001) 2.85
Expression of Light-Harvesting Chlorophyll a/b-Protein Genes Is Phytochrome-Regulated in Etiolated Arabidopsis thaliana Seedlings. Plant Physiol (1988) 2.85
Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J (1997) 2.71
A Prothrombin Conversion Accelerator in Serum. Science (1949) 2.64
TATA element recognition by the TATA box-binding protein has been conserved throughout evolution. Genes Dev (1999) 2.50
The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell (2001) 2.45
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39
High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res (1999) 2.29
Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science (1999) 2.17
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A (1989) 2.15
Preparation and measurement of three-qubit entanglement in a superconducting circuit. Nature (2010) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
The specificity of different classes of ethylating agents toward various sites of HeLa cell DNA in vitro and in vivo. Biochemistry (1975) 2.14
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med (2000) 2.09
Umbilical cord mesenchymal stem cell transplantation in drug-induced Stevens-Johnson syndrome. J Eur Acad Dermatol Venereol (2012) 2.03
Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Scand J Rheumatol (2013) 2.02
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
Intestinal mucins in health and disease. Digestion (1978) 1.94
Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat Biotechnol (1998) 1.92
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med (1998) 1.81
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med (1971) 1.79
Realization of three-qubit quantum error correction with superconducting circuits. Nature (2012) 1.76
Monoclonal rat antibodies to murine IgM determinants. J Immunol Methods (1981) 1.75
Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science (1986) 1.75
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol (2000) 1.66
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int (2007) 1.64
Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol (1997) 1.63
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.58
Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem (1995) 1.57
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development (2000) 1.57
Goblet cell mucin of rat small intestine. Chemical and physical characterization. Can J Biochem (1973) 1.55
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Protein trans-splicing and cyclization by a naturally split intein from the dnaE gene of Synechocystis species PCC6803. J Biol Chem (2000) 1.53
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol (2008) 1.49
Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. Nucleic Acids Res (1998) 1.49
Childhood sexual abuse among homosexual men. Prevalence and association with unsafe sex. J Gen Intern Med (1997) 1.49
Detection of submicroscopic chromosomal aberrations by array-based comparative genomic hybridization in fetuses with congenital heart disease. Ultrasound Obstet Gynecol (2014) 1.48
Antigenic and structural features of goblet-cell mucin of human small intestine. Biochem J (1984) 1.48
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica (2008) 1.48
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane pores. Biophys J (1990) 1.47
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy. Leukemia (2009) 1.46
A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J (2005) 1.46
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Lysogenization by satellite phage P4. Virology (1981) 1.43
Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proc Natl Acad Sci U S A (1999) 1.43
Heterogeneity of rat goblet-cell mucin before and after reduction. Biochem J (1983) 1.42
The Pex16p homolog SSE1 and storage organelle formation in Arabidopsis seeds. Science (1999) 1.42
Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry (2001) 1.40
Conflict resolution at the University of Ottawa Faculty of Medicine: The Pelican and the sign of the triangle. Acad Med (2001) 1.40
Color flow ultrasound for delineating microsurgical vessels: a clinical and experimental study. Ann Plast Surg (1993) 1.40
Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J (1984) 1.40
The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology (1997) 1.40
Nano DCPA-whisker composites with high strength and Ca and PO(4) release. J Dent Res (2006) 1.39
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum (1996) 1.39
Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res (2012) 1.37
Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun (2000) 1.36
Determination of capsid size by satellite bacteriophage P4. Proc Natl Acad Sci U S A (1978) 1.35
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
Potential metabolite markers of schizophrenia. Mol Psychiatry (2011) 1.35
The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals. Biochem J (1989) 1.33
Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine. Biochim Biophys Acta (1987) 1.33
Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry (1997) 1.32